No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 5, 2007, Pages 878-882

  Richards Jr , Frank O ^a   Amann, Josef ^b   Arana, Byron ^c   Punkosdy, George ^b   Klein, Robert ^c   Blanco, Carlos ^d   Lopez, Beatriz ^c   Mendoza, Carlos ^c   Domínguez, Alfredo ^e   Guarner, Jeannette ^b   Maguire, James H ^b   Eberhard, Mark ^f  

^a CARTER CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSIDAD DEL VALLE DE GUATEMALA   (Guatemala)

^d Laboratorio Nacional de Salud de Guatemala   (Guatemala)

^e Oficina 1401   (Guatemala)

^f Division of Parasitic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; IVERMECTIN; MULTIVITAMIN; RIFAMPICIN; RIFAMPICINA; ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOSYMBIOSIS; FEMALE FERTILITY; GUATEMALA; HUMAN; MAJOR CLINICAL STUDY; MICROFILARIA (NEMATODE LARVA); MONOTHERAPY; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SKIN BIOPSY; TREATMENT OUTCOME; WOLBACHIA; ADOLESCENT; ADULT; ANIMAL; CHILD; DRUG COMBINATION; DRUG EFFECT; FEMALE; MALE; MICROBIOLOGY; MIDDLE AGED; PARASITOLOGY; PRESCHOOL CHILD;

ONCHOCERCA VOLVULUS; WOLBACHIA;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; RIFAMPIN; WOLBACHIA;

EID: 42949110845     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.878     Document Type: Article

References (28)

1. Boatin BA. Richards FO Jr, 2006. Control of onchocerciasis. Adv Parasitol 61: 349-394.
2. Hoerauf A, Buttner DW, Adjei O, Pearlman E, 2003. Onchocerciasis. BMJ 25: 207-210.
3. Alleman MM, Twum-Danso NA, Thylefors BI, 2006. The Mectizan® donation program - highlights from 2005. Filaria J 5: 11.
4. Dadzie KY, Neira M, Hopkins D, 2003. Final report of the conference on the eradicability of onchocerciasis. Filaria J 2: 2-32.
5. Alley WS, van Oortmarssen GJ, Boatin BA, Nagelkerke N, Plaisier AP, Remme J, Lazdins J, Borsboom G, Habbema JD, 2001. Macrofilaricides and onchocerciasis control, mathematical modeling of the prospects for elimination. BMC Public Health 1: 12.
6. Hopkins DR, Richards FO, Katabarwa M, 2005. Whither onchocerciasis control in Africa? Am J Trop Med Hyg 72: 1-2.
7. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, Buttner DW, 2000. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355: 1242-1243.
8. Taylor MJ, Hoerauf A, 2001. A new approach to the treatment of filariasis. Curr Opin Infect Dis 14: 727-731.
9. Hoerauf A, Mand S, Adjei O, Fleischer B, Buttner DW, 2001. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357: 1415-1416.
10. Hoerauf A, Mand S, Volkmann L, Buttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Buttner DW, 2003. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 5: 261-273.
11. Hoerauf A, Adjei O, Buttner DW, 2002. Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr Opin Investig Drugs 3: 533-537.
12. Townson S, Hutton D, Siemienska J, Hollick L, Scanlon T, Tagboto SK, Taylor MJ, 2000. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. Ann Trop Med Parasitol 94: 801-816.
13. Volkmann L, Fischer K, Taylor M, Hoerauf A, 2003. Antibiotic therapy in murine filariasis (Litomosoides signodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability. Trop Med Int Health 8: 392-401.
14. 2007. Physicians' Desk Reference. 61st edition. Montvale, NJ: Thomson PDR.
15. Schulz-Key H, 1978. A simple technique to assess the total number of Onchocerca volvulus microfilariae in skin snips. Trop Med Parasitol 29: 51-54.
16. Plaisier AP, Alley ES, Boatin BA, van Oortmarssen GJ, Remme H, de Vlas SJ, Bonneux L, Habbema JD, 1995. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis 172: 204-210.
17. Remme JH, 2004. Research for control: the onchocerciasis experience. Trop Med Int Health 9: 243-254.
18. Duke BO, Zea-Flores G, Muñoz B, 1991. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin. Trop Med Parasitol 42: 175-180.
19. Albiez EJ, Buttner DW, Duke BO, 1988. Diagnosis and extirpation of nodules in human onchocerciasis. Trop Med Parasitol 39: 331-346.
20. Duke BO, 1990. An improved method of examining adult On chocerca volvulus worms. Trop Med Parasitol 41: 25-28.
21. Duke BO, Zea-Flores G, Gannon RT, 1990. On the reproductive activity of female Onchocerca volvulus. Trop Med Parasitol 41: 387-402.
22. Cedillos RA, Warren M, Jeffrey GM, 1978. Field evaluation of primaquine in the control of Plasmodium vivax. Am J Trop Med Hyg 27: 466-472.
23. Anonymous, 2006. Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela. Wkly Epidemiol Rec 81: 293-296.
24. Cupp EW, Cupp MS, 2005. Impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg 73: 1159-1161.
25. World Health Organization, 2001. Certification of Elimination of Human Onchocerciasis: Criteria and Procedures, Guidelines. Geneva: World Health Organization. WHO/CDS/CPE/CEE/ 2001.18.b.
26. Cupp EW, Duke BOL, Mackenzie CD, Guzman JR, Vieira JC, Mendez-Galvan J, Castro J, Richards F, Sauerbrey M, Dominguez A, Eversole RR, Cupp MS, 2004. The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg 71: 602-607.
27. Newell JN, Baral SC, Pande SB, Barn DS, Mall P, 2006. Family member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 367: 903-939.
28. Osei-Atweneboana MY, Eng JKL, Boakye DA, Gyapong JO, Prichard RK, 2007. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 2021-2029.